Imatinib Mesylate

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Imatinib Mesylate
CAS No.:220127-57-1
Standard:In-house Standards
Company:Changzhou Comwin Fine Chemicals Co., Ltd.

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Jiangsu Province

    Main Sales Markets: Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa

  • Monthly Production Capacity: 200kg/month

    Packaging Information: 5kg/drum

  • Delivery Lead Time: 1-4 weeks

    Sample Provided: yes

    Payment Terms: L/L

    Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for disease that has recurred (come back) or is refractory (does not respond to treatment). In children, it is used with chemotherapy as the first treatment after the disease is diagnosed.

Send your message to this supplier
  • From:
  • To:
    Changzhou Comwin Fine Chemicals Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service